{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:15:43Z","timestamp":1791299743822,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-20-0029452"],"award-info":[{"award-number":["G-20-0029452"]}],"id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-22-0032139"],"award-info":[{"award-number":["G-22-0032139"]}],"id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.dmd.2026.100339","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:21:23Z","timestamp":1780327283000},"page":"100339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of organic anion transporting polypeptides in pancreatic statin disposition and islet cell function in mice"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2916-5955","authenticated-orcid":false,"given":"Chen Bei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6109-5029","authenticated-orcid":false,"given":"Rennian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-3960","authenticated-orcid":false,"given":"Rommel G.","family":"Tirona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1569-1580","authenticated-orcid":false,"given":"Ute I.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dmd.2026.100339_bib1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2014.02.014","article-title":"Statin treatment and new-onset diabetes: a review of proposed mechanisms","volume":"63","author":"Brault","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.dmd.2026.100339_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.03.010","article-title":"Mechanisms of statin-associated skeletal muscle-associated symptoms","volume":"154","author":"Bouitbir","year":"2020","journal-title":"Pharmacol Res"},{"issue":"24","key":"10.1016\/j.dmd.2026.100339_bib3","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"issue":"9716","key":"10.1016\/j.dmd.2026.100339_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.dmd.2026.100339_bib5","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00125-015-3528-5","article-title":"Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort","volume":"58","author":"Cederberg","year":"2015","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.dmd.2026.100339_bib6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-8587(24)00040-8","article-title":"Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis","volume":"12","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9841","key":"10.1016\/j.dmd.2026.100339_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.dmd.2026.100339_bib8","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1161\/ATVBAHA.121.316159","article-title":"Statins are associated with increased insulin resistance and secretion","volume":"41","author":"Abbasi","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11883-024-01270-y","article-title":"Debate: lipid-lowering therapies and diabetes development","volume":"27","author":"Brandts","year":"2025","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"10.1016\/j.dmd.2026.100339_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2024.100023","article-title":"Organic anion transporting polypeptides: Pharmacology, toxicology, structure, and transport mechanisms","volume":"77","author":"Hagenbuch","year":"2025","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/dmd.113.054783","article-title":"Utility of Oatp1a\/1b-knockout and OATP1B1\/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein","volume":"42","author":"Higgins","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.dmd.2026.100339_bib12","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1021\/mp300108c","article-title":"Organic anion-transporting polypeptides 1a\/1b control the hepatic uptake of pravastatin in mice","volume":"9","author":"Iusuf","year":"2012","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.dmd.2026.100339_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy--a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.dmd.2026.100339_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.fpc.0000114750.08559.32","article-title":"High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)","volume":"14","author":"Niemi","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"5","key":"10.1016\/j.dmd.2026.100339_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01213011-200505000-00005","article-title":"Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype \u221717","volume":"15","author":"Niemi","year":"2005","journal-title":"Pharmacogenetics Genom"},{"issue":"3","key":"10.1016\/j.dmd.2026.100339_bib16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2133\/dmpk.25.274","article-title":"The HMG-CoA reductase inhibitor pravastatin stimulates insulin secretion through organic anion transporter polypeptides","volume":"25","author":"Abe","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"issue":"4","key":"10.1016\/j.dmd.2026.100339_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00418-017-1580-6","article-title":"Characterization of OATP1B3 and OATP2B1 transporter expression in the islet of the adult human pancreas","volume":"148","author":"Kim","year":"2017","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"10.1016\/j.dmd.2026.100339_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/CIRCRESAHA.109.203596","article-title":"Human skeletal muscle drug transporters determine local exposure and toxicity of statins","volume":"106","author":"Knauer","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.dmd.2026.100339_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1755-8794-2-3","article-title":"Detailed transcriptome atlas of the pancreatic beta cell","volume":"2","author":"Kutlu","year":"2009","journal-title":"BMC Med Genomics"},{"issue":"2","key":"10.1016\/j.dmd.2026.100339_bib20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2337\/db13-1005","article-title":"OATP1B3 is expressed in pancreatic \u03b2-islet cells and enhances the insulinotropic effect of the sulfonylurea derivative glibenclamide","volume":"63","author":"Meyer zu Schwabedissen","year":"2014","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.dmd.2026.100339_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/15376516.2023.2262568","article-title":"Differential effects of OATP2B1 on statin accumulation and toxicity in a beta cell model","volume":"34","author":"Kwon","year":"2024","journal-title":"Toxicol Mech Methods"},{"issue":"3","key":"10.1016\/j.dmd.2026.100339_bib22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1534\/genetics.115.179432","article-title":"e al. Identification of the bile acid transporter Slco1a6 as a candidate gene that broadly affects gene expression in mouse pancreatic islets","volume":"201","author":"Tian","year":"2015","journal-title":"Genetics"},{"issue":"3","key":"10.1016\/j.dmd.2026.100339_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151592","article-title":"Rosuvastatin treatment affects both basal and glucose-induced insulin secretion in INS-1 832\/13 cells","volume":"11","author":"Salunkhe","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.dmd.2026.100339_bib24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.bjp.0702397","article-title":"Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet \u03b2-cells","volume":"126","author":"Yada","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.dmd.2026.100339_bib25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1124\/mol.112.081927","article-title":"Murine Oatp1a\/1b uptake transporters control rosuvastatin systemic exposure without affecting its apparent liver exposure","volume":"83","author":"Iusuf","year":"2013","journal-title":"Mol Pharmacol"},{"issue":"8","key":"10.1016\/j.dmd.2026.100339_bib26","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1124\/dmd.114.057976","article-title":"Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins","volume":"42","author":"Salphati","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/19382014.2015.1024405","article-title":"Structural similarities and differences between the human and the mouse pancreas","volume":"7","author":"Dolen\u0161ek","year":"2015","journal-title":"Islets"},{"issue":"9","key":"10.1016\/j.dmd.2026.100339_bib28","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.bbadis.2019.04.012","article-title":"Cholesterol metabolism, pancreatic \u03b2-cell function and diabetes","volume":"1865","author":"Perego","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/path.4652","article-title":"GGPPS-mediated Rab27A geranylgeranylation regulates \u03b2 cell dysfunction during type 2 diabetes development by affecting insulin granule docked pool formation","volume":"238","author":"Jiang","year":"2016","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2337\/db19-0178","article-title":"Atorvastatin targets the islet mevalonate pathway to dysregulate mTOR signaling and reduce \u03b2-cell functional mass","volume":"69","author":"Shen","year":"2020","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.dmd.2026.100339_bib31","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.2337\/db19-0996","article-title":"\u03b2-cell-specific deletion of HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase causes overt diabetes due to reduction of \u03b2-cell mass and impaired insulin secretion","volume":"69","author":"Takei","year":"2020","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101171","article-title":"A protocol for studying glucose homeostasis and islet function in mice","volume":"3","author":"Al Rijjal","year":"2022","journal-title":"STAR Protoc"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2164-8-127","article-title":"Housekeeping and tissue-specific genes in mouse tissues","volume":"8","author":"Kouadjo","year":"2007","journal-title":"BMC Genom"},{"issue":"6","key":"10.1016\/j.dmd.2026.100339_bib34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"issue":"8","key":"10.1016\/j.dmd.2026.100339_bib35","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1124\/dmd.119.087619","article-title":"Fexofenadine and rosuvastatin pharmacokinetics in mice with targeted disruption of organic anion transporting polypeptide 2B1","volume":"47","author":"Medwid","year":"2019","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2026.100339_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0016-5107(00)70417-2","article-title":"Endoscopic measurement of pancreatic tissue perfusion in patients with chronic pancreatitis and control patients","volume":"51","author":"Lewis","year":"2000","journal-title":"Gastrointest Endosc"},{"issue":"48","key":"10.1016\/j.dmd.2026.100339_bib37","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.3748\/wjg.v16.i48.6046","article-title":"Regulation of hepatic blood flow: the hepatic arterial buffer response revisited","volume":"16","author":"Eipel","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.dmd.2026.100339_bib38","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/RCT.0b013e318223f0c5","article-title":"Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging","volume":"35","author":"Delrue","year":"2011","journal-title":"J Comput Assist Tomogr"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3181\/00379727-75-18083","article-title":"Plasma and blood volumes of mouse organs, as determined with radioactive iodoproteins","volume":"75","author":"Kaliss","year":"1950","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/jpet.102.043026","article-title":"Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation","volume":"304","author":"Tirona","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dmd.2026.100339_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105951","article-title":"Pre-incubation with OATP1B1 and OATP1B3 inhibitors potentiates inhibitory effects in physiologically relevant sandwich-cultured primary human hepatocytes","volume":"165","author":"Farasyn","year":"2021","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"10.1016\/j.dmd.2026.100339_bib42","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1124\/dmd.113.051052","article-title":"Integrated approach of in vivo and in vitro evaluation of the involvement of hepatic uptake organic anion transporters in the drug disposition in rats using rifampicin as an inhibitor","volume":"41","author":"Imaoka","year":"2013","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.dmd.2026.100339_bib43","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1124\/dmd.118.080770","article-title":"Transport kinetics, selective inhibition, and successful prediction of in vivo inhibition of rat hepatic organic anion transporting polypeptides","volume":"46","author":"Ishida","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.dmd.2026.100339_bib44","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1124\/dmd.105.003640","article-title":"Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (oatps)","volume":"33","author":"Cheng","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2026.100339_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111618","article-title":"Discovery of farnesoid X receptor and its role in bile acid metabolism","volume":"548","author":"Chiang","year":"2022","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"10.1016\/j.dmd.2026.100339_bib46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4161\/isl.22383","article-title":"The significance of the nuclear farnesoid X receptor (FXR) in \u03b2 cell function","volume":"4","author":"D\u00fcfer","year":"2012","journal-title":"Islets"},{"issue":"4","key":"10.1016\/j.dmd.2026.100339_bib47","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00271033","article-title":"Detection of P-glycoprotein on endothelial and endocrine cells of the human pancreatic islets by C 494 monoclonal antibody","volume":"98","author":"Bani","year":"1992","journal-title":"Histochemistry"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2005.04.024","article-title":"Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues","volume":"235","author":"Fetsch","year":"2006","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.dmd.2026.100339_bib49","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/tri.12617","article-title":"Intracellular sirolimus concentration is reduced by tacrolimus in human pancreatic islets in vitro","volume":"28","author":"Kloster-Jensen","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.dmd.2026.100339_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116644","article-title":"Interplay of OATP1A\/1B\/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs","volume":"175","author":"Li","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10.1016\/j.dmd.2026.100339_bib51","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1172\/JCI42168","article-title":"Organic anion transporting polypeptide 1a\/1b\u2013knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs","volume":"120","author":"van de Steeg","year":"2010","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.dmd.2026.100339_bib52","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1053\/j.gastro.2006.02.034","article-title":"Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics","volume":"130","author":"Ho","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dmd.2026.100339_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107073","article-title":"Comparative uptake of statins by hepatic organic anion transporting polypeptides","volume":"209","author":"Kiander","year":"2025","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib54","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/dmd.109.029454","article-title":"Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier","volume":"38","author":"Ose","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1016\/j.dmd.2026.100339_bib55","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s11095-010-0216-5","article-title":"Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide","volume":"27","author":"Shirasaka","year":"2010","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.dmd.2026.100339_bib56","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1177\/0091270011422815","article-title":"Disposition of atorvastatin, rosuvastatin, and simvastatin in Oatp1b2-\/- mice and intraindividual variability in human subjects","volume":"52","author":"DeGorter","year":"2012","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2026.100339_bib57","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/mol.119.118083","article-title":"Interactions between atorvastatin and the farnesoid X receptor impair insulinotropic effects of bile acids and modulate diabetogenic risk","volume":"97","author":"Hoffmeister","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.dmd.2026.100339_bib59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ebiom.2016.07.007","article-title":"Dual effect of rosuvastatin on glucose homeostasis through improved insulin sensitivity and reduced insulin secretion","volume":"10","author":"Salunkhe","year":"2016","journal-title":"EBioMedicine"},{"issue":"39","key":"10.1016\/j.dmd.2026.100339_bib58","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004906","article-title":"Atorvastatin inhibits insulin synthesis by inhibiting the Ras\/Raf\/ERK\/CREB pathway in INS-1 cells","volume":"95","author":"Sun","year":"2016","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib60","article-title":"Effects of simvastatin on glucose metabolism in mouse MIN6 cells","volume":"2014","author":"Zhou","year":"2014","journal-title":"J Diabetes Res"},{"issue":"4","key":"10.1016\/j.dmd.2026.100339_bib61","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3390\/jcm13041179","article-title":"Interactions between the exocrine and the endocrine pancreas","volume":"13","author":"Valente","year":"2024","journal-title":"J Clin Med"},{"issue":"17","key":"10.1016\/j.dmd.2026.100339_bib62","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.jacc.2007.01.067","article-title":"Safety of aggressive lipid management","volume":"49","author":"Davidson","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.dmd.2026.100339_bib63","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCGENETICS.113.000099","article-title":"Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care","volume":"6","author":"DeGorter","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"issue":"6","key":"10.1016\/j.dmd.2026.100339_bib64","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0009-9236(96)90218-0","article-title":"Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects","volume":"60","author":"Cilla","year":"1996","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.dmd.2026.100339_bib65","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.dmd.2026.100339_bib66","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pharmthera.2006.03.003","article-title":"Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug\u2013drug interactions and interindividual differences in transporter and metabolic enzyme functions","volume":"112","author":"Shitara","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dmd.2026.100339_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48262-6","article-title":"Protective effect of nobiletin on isolated human islets survival and function against hypoxia and oxidative stress-induced apoptosis","volume":"9","author":"Keshtkar","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.dmd.2026.100339_bib69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1055\/a-2190-2803","article-title":"Mechanistic insights into ferroptotic cell death in pancreatic islets","volume":"56","author":"Schepp","year":"2024","journal-title":"Horm Metab Res"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626006082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626006082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T21:07:17Z","timestamp":1786568837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626006082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0090955626006082"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100339","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of organic anion transporting polypeptides in pancreatic statin disposition and islet cell function in mice","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100339"}}